Ledger.Open graph →
SEC Form D · filed October 24, 2014

Syros Pharmaceuticals, Inc

Offering
$53.1M
Sold
$53.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Douglas E. Cole · Watertown, MADirectorNancy Simonian · Watertown, MAExec · DirectorVicki E. Sato · Watertown, MADirectorRobert E. Nelsen · Watertown, MADirectorJames E. Bradner · Watertown, MADirectorRichard A. Young · Watertown, MADirectorPhilip E. Sharp · Watertown, MADirectorPhilip R. Cater · GEORGE TOWN, GRAND CAYMAN, Cayman IslandsDirectorEric T. Bednash · Fulton, MDDirectorAtalanta Sosnoff Capital, LLC · New York, NYExec · DirectorJorge Conde · Cambridge, MAExecStephane Bancel · Waltham, MADirectorDarren Stainrod · Grand Cayman, Cayman IslandsDirectorMark H. Kreloff · BOULDER, CODirectorAndrew H. Brandt · BOULDER, CODirectorMarc H. Callipari · BOULDER, CODirectorRichard A. Young · Watertown, MAExec · DirectorVicki E. Sato · Watertown, MADirectorPhilip E. Sharp · Watertown, MADirectorJorge Conde · Watertown, MAExecStephane Bancel · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗